ClinicalTrials.govpublic full text
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
metabolic syndrome, diabete type 2, kidney insufficiency
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 146293
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.